Navigation Links
Survey of Oncologists Reveals 98.9% of Physicians Experienced Cancer Drug Shortages in Last 12 Months
Date:11/15/2012

WASHINGTON, Nov.15, 2012 /PRNewswire/ -- The Community Oncology Alliance (COA), a non-profit organization dedicated to preserving and fostering community cancer care, announced the results of a drug shortage survey of 200 member practices representing 525 physicians across the United States.  98.9% of the respondents reported experiencing a drug shortage in the last year.   Survey participants indicated that the cancer progressed more quickly in more than 60 percent of patients as a result of the drug shortages, and more than 70 percent of patients had more severe side effects as a result of drug shortages.  

Almost half of those surveyed reported seeing more than one patient per day affected by a drug shortage and 58.2% indicate the shortage in cancer care drugs is increasing.  Over 80% of the patients and over 90% of the practices affected by a cancer drug shortage also experienced a more severe financial burden.

"The root cause of the drug shortage is economic," said Ted Okon, executive director of COA.  "The Medicare system for reimbursing for cancer drugs has created pricing instability.   That has resulted in disincentives for manufactures to produce these low-cost but vital generic cancer drugs, as well as to invest in manufacturing facilities for these products."

In addition to issues of optimal treatment, drug substitutions made because of a shortage often result in patients facing significantly higher costs.  

"When treating ovarian cancer, a commonly used drug is leucovorin.  The cost to Medicare is $35 per dose; the patient co-payment is $9.  But leucovrin is a generic drug and in short supply," says Dr. Patrick Cobb, an oncologist at the Frontier Cancer Centers and Blood Institute, Billings, Montana, and COA past president.  "The substitute is a branded drug that is readily available.  The cost to Medicare for a dose of the branded drug is $2,000 and the cost to the patient is $520.  This is an unacceptable consequence of the drug shortage crisis."

The complete survey results and comments from respondents are available at http://www.communityoncology.org/site/coa-studies.htm.

About Community Oncology Alliance (COA)
Formed in 2003 by community oncologists, COA is a non-profit organization dedicated solely to community oncology, where four out of five Americans with cancer are treated.   COA has mobilized community oncology to become more politically active, and increased awareness on Capitol Hill about the community cancer care delivery system. Additionally, COA has brought together community oncology practices from across the country to share information in order to enhance the effectiveness and efficiency of the cancer care they provide to their patients. COA also has a multi-stakeholder group involved with the implementation of the Oncology Medical Home, a cancer care model that fosters quality and value in cancer care. More information can be found at www.communityoncology.org.                                                      


'/>"/>
SOURCE Community Oncology Alliance
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
2. As Smartphone Usage Expands, Survey Says Nurses and Nursing Students Want Mobile Access to Credible Drug Data
3. Survey Shows eContent Critical to Corporate Strategies
4. Global Pharmaceutical Survey 2012-2013: Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry
5. Global Pharmaceutical Survey 2012-2013: Market Trends, Buyer Spend and Procurement Strategies in the Global Pharmaceutical Industry
6. Global Medical Devices Survey 2012-2013: Market Trends, Buyer Spend and Procurement Strategies in the Global Medical Devices Industry
7. "AWAKEN" Survey Finds Only 50 Percent of Americans Understand Significant Health Impact of Narcolepsy, and Many Physicians Not Comfortable Diagnosing the Sleep Disorder
8. Pharma Execs Continue Looking For Growth Opportunities In Spite Of Increasing Regulatory Challenges: KPMG Survey
9. Supplier Marketing Spend Activity, Marketing and Sales Behaviors and Strategies in the Medical Devices Industry - 2012-2013 : Survey Intelligence
10. Buyer Spend Activity and Procurement Behaviors and Strategies in the Pharmaceutical Industry - 2012-2013 : Survey Intelligence
11. Hologic Breast Tomosynthesis (3D Mammography) System Places First in KLAS Annual Survey of Mammography Equipment Users
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... NORTHBROOK, Ill. and BOGOTA, Colombia , June 23, 2016  Astellas today announced the ... joins Astellas Farma Brasil as the company,s second affiliate in Latin America . ... ... appointed General Manager of Astellas Farma Colombia ... ...
(Date:6/23/2016)... June 23, 2016  Guerbet announced today that it ... Supplier Horizon Award . One of 12 ... recognized for its support of Premier members through exceptional ... excellence, and commitment to lower costs. ... recognition of our outstanding customer service from Premier," says ...
(Date:6/23/2016)... -- Research and Markets has announced the ... (United States, China, Japan, Brazil, United Kingdom, Germany, France, ... Surgical Procedure Volumes: ... provides surgical procedure volume data in a geographic context. ... analysis of growth drivers and inhibitors, including world population ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media Slicing Effect ... videos a whole new perspective by using the title layers in ProSlice Levels ... , ProSlice Levels contains over 30 Different presets to choose from. FCPX ...
(Date:6/25/2016)... , ... June 25, 2016 , ... Austin residents seeking ... American College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical ... effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin ... injury. Recently, he has implemented orthobiologic procedures as a method for treating his ... of the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is ... associated with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of ...
(Date:6/24/2016)... ... 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited to ... Recovery® program to drive cancer patients to and from their cancer treatments. Comfort ... quality of life and ongoing independence. Getting to and from medical treatments is ...
Breaking Medicine News(10 mins):